Intelligent Bio Solutions Inc. Files 8-K
Ticker: INBS · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1725430
Sentiment: neutral
Topics: regulatory-filing, financial-statements
TL;DR
INTL Bio Solutions filed an 8-K on 3/26/25. Financials and Reg FD update.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on March 26, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as GBS Inc., is incorporated in Delaware and has its principal executive offices in New York City.
Why It Matters
This filing indicates a regulatory disclosure and the submission of financial documents, which are important for investors to stay informed about the company's financial status and compliance.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain specific material non-public information that would inherently increase risk.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- March 26, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What was Intelligent Bio Solutions Inc. formerly known as?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
When was the report filed?
The report was filed on March 26, 2025.
Where are the principal executive offices of Intelligent Bio Solutions Inc. located?
The principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).